Type 2 Diabetes Treatment market is growing at a considerable CAGR of 6.6% during the forecast period (2023-2029). Type 2 diabetes accounts for around 90.0% of the total number of diabetes cases across the globe. The factors that contribute to the market growth are the rise in the level of obesity, lack of physical activity, and rise in the geriatric population. Moreover, family history of diabetes also plays a major role as according to the reports of the Centers for Diabetes Control and Preventions (CDC), one is likely to get diabetes if one’s family has one. People with prediabetes and gestational diabetes are more likely to get type 2 diabetes. In addition to this, consumption of an unhealthy diet and an increase in the prevalence of high blood pressure are some of the other factors that drive the growth of the type 2 diabetes treatment market.
However, inadequate funding and staff numbers in the undeveloped economy, high cost of the diagnosis and treatment, and complications with insulin for certain people are some of the constraints that are estimated to hamper the growth of the market in the forecast period. Conversely, government initiatives to control rising cases of diabetes and technological advancement are the opportunities estimated for the market players. For instance, in February 2020, AstraZeneca India launched Qtern® (Dapagliflozin 10mg + Saxagliptin 5mg film Coated Tablets) which is considered as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus (T2DM).
To Request a Sample of our Report on Type 2 Diabetes Treatment Market: https://www.omrglobal.com/request-sample/type-2-diabetes-market
Type 2 Diabetes Treatment Segmentation
By Technology
- Immunohistochemistry
- In-Situ Hybridization
- H&E Stain
- Special Staining
- Digital Pathology
- Others
By Diagnosis
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Carcinoma
- Others
By Product
- Instrument
- Consumables
By End-User
- Hospitals & Clinics
- Laboratories & Research Institutes
- Others
A full Report of Type 2 Diabetes Treatment Market is Available @ https://www.omrglobal.com/industry-reports/type-2-diabetes-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Agilent Technologies
- Allengers Medical Systems Ltd.
- AliveCor Inc.
- Becton, Dickinson & Company
- Bio SB Inc.
- Biocept
- Bio-Genex Laboratories
- bioMérieux SA
- Caris Life Science
- Cell Signalling Technology, Inc.
- Danaher Corp.
- Eurogentec
- GE Healthcare
- Grifols Diagnostic Solutions Inc.
- Hoffmann-La Roche AG
- Johnson & Johnson
- Novodiax Inc.
- Koninklijke Philips N.V.
- Prometheus Laboratories
- Quest Diagnostics
- Siemens AG
- Stryker Corp.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/type-2-diabetes-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
